GlassScriptPhysician profile
Amy Elisabeth Weeks
NPI 1225771595
$1,648.59
in general payments reported to CMS, 2019-2025
28 companies · $894 in 2025
The $894 reported for 2025 was more than what 83% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.23 · 2024: $742 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,648.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $368.48 | 2024-2025 | Orgovyx, Gemtesa |
| Convatec INC. | $136.59 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $102.12 | 2024-2025 | Prolaris, Myrisk |
| Ferring Pharmaceuticals INC. | $99.84 | 2025 | Adstiladrin |
| Abbvie INC. | $96.72 | 2025 | |
| Urogen Pharma, INC. | $80.94 | 2024-2025 | |
| Astellas Pharma US INC | $73.69 | 2024-2025 | Xtandi |
| Axonics, INC. | $63.66 | 2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $57.35 | 2024-2025 | Provenge |
| Tempus Ai, INC | $56.28 | 2024-2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $54.43 | 2024-2025 | Keytruda, Keytruda Qlex |
| Medtronic, INC. | $49.27 | 2024 | Interstim |
| Boston Scientific Corporation | $42.96 | 2025 | Axonics, Ams 700 |
| Bayer Healthcare Pharmaceuticals INC. | $42.62 | 2025 | |
| Procept Biorobotics Corporation | $38.32 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $37.49 | 2025 | Posluma |
| Vertex Pharmaceuticals Incorporated | $30.35 | 2025 | |
| Sun Pharmaceutical Industries INC. | $28.59 | 2025 | |
| Endo USA, INC. | $24.49 | 2024 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $22.48 | 2025 | Lynparza |
| Agiliti Surgical, INC. | $22.11 | 2025 | Quanta System Fiber Dust Tfl Laser, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology, Sonablate Hifu |
| Laborie Medical Technologies Corp. | $21.62 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $19.76 | 2024 | |
| Progenics Pharmaceuticals, INC. | $18.85 | 2025 | |
| Olympus America INC. | $16.03 | 2025 | Itind System |
| Pfizer INC. | $15.72 | 2024 | |
| Verity Pharmaceuticals INC. | $14.60 | 2024 | Trelstar |
| Aurinia Pharma U.S., INC. | $13.23 | 2023 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.